In Nature this week: lack of diversity in genomic studies, and more.
IBM is to make its Watson technology available to its employees to identify what cancer treatments might work for them, the Wall Street Journal reports.
Researchers hope to increase the genetic diversity of bison in Minnesota, the Associated Press reports.
Nature News writes that efforts like ExAC are enabling researchers to call some seemingly disease-linked variants as benign.
In Genome Research this week: Sus scrofa genetic variants, translational plasticity might minimize effects of harmful mutations, and more.
A hedge fund that invested in Theranos files a lawsuit, the Wall Street Journal reports.
According to Retraction Watch, Ohio State University's Carlo Croce retracts a commentary over "irreconcilable differences with the journal editors."
At the Guardian, Jenny Rohn describes one ongoing approach to promote equality in the sciences.
In PNAS this week: mutation patterns in uterine and ovarian carcinosarcomas, deep genome sequences, and more.
A nonprofit organization is to launch a precision medicine trial for pancreatic cancers, Technology Review reports.
An agriculture company is focusing on products inspired by endophyte bacteria, Wired reports.
The Boston Globe writes that some volunteers want control or compensation for having given biological samples for research.
In PLOS this week: germline variants in prostate cancer risk genes, genome of a Zika virus from patient without neurological complications, and more.
NIH Director Francis Collins describes changes to improve clinical trials in JAMA this week.
People with loss-of-function mutations in the MC4R gene prefer high-fat food, but not high-sugar foods, researchers report.
Nobel laureates are often over 50 years old and men, leading some to suggest that changes need to be made to the prizes.
In Science this week: focus on genetics and the environment, and more.
In an open letter, Theranos CEO says the embattled firm is focusing on the commercialization of its miniLab platform.
Two newly minted Nobel laureates lament Brexit's effect on UK science, the Guardian reports.
Genomic testing can gauge whether cancer patients may need chemotherapy after surgery or forgo it, the Democrat and Chronicle reports.
In Nature this week: genome of a Korean individual, genomic study of ancient settlers of Vanuatu and Tonga, and more.
A crowdsourcing effort aims to collect data to study metastatic breast cancer, the Associated Press reports.
A koala genome bank aims to increase healthy genes in its population and reduce chlamydia infections, according to Australian Geographic.
An Irish agriculture official says genomics could be used to fight cattle rustlers, according to AgriLand.
In Genome Biology this week: rare CNVs and gene signatures of human cancer linked with survival, Mediterranean fruit fly genome assembly, and more.
Bitesize Bio's Gail Seigel offers some tips on running a low-budget lab.
The GRE isn't a good predictor of graduate school performance or productivity, according to two PLOS One studies.
Bitesize Bio has some advice for scientists ready to leave their current lab behind.
A trio of editors from the Nature family of journals describes what make a peer review a good one.